Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Big Pharma
Two subsidiaries of Ireland-based Jazz Pharmaceuticals have failed in their bid to challenge the jurisdiction of the English High Court in a dispute with Tokyo-headquartered Otsuka Pharmaceutical over a cannabis sativa collaboration.   4 May 2022
article
The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.   3 May 2022
article
A scientist working in Switzerland has been convicted of conspiring with his sister and others to steal trade secrets from GlaxoSmithKline for the benefit of their respective biopharmaceutical ventures.   3 May 2022
Medtech
The US Court of Appeals for the Federal Circuit has renewed Auris Health’s attempt to invalidate Intuitive Surgical’s patent covering a robotic surgical tool.   3 May 2022
Americas
AstraZeneca filed a patent infringement lawsuit against Mylan Pharmaceuticals and Kindeva Drug Delivery on Tuesday, claiming that their generic asthma Symbicort infringes a brand-new patent that was issued the same day.   28 April 2022
Americas
Akerman has hired Atlanta-based patent litigator Jeffrey Toney from McDermott Will & Emery.   28 April 2022
Big Pharma
US pharmaceutical and medical device industries have expressed concerns regarding the policies of several countries, according to the Office of the US Trade Representatives.   28 April 2022
Generics
BioMarin Pharmaceutical and MSD, have sued Aurobindo Pharmaceuticals for patent infringement in a dispute over the drug Kuvan, used to treat a rare genetic disorder.   26 April 2022
Big Pharma
Senator Elizabeth Warren has urged the US Department of Health and Human Services to “break patent barriers” in order to foster competition to lower prescription drug prices.   26 April 2022
Generics
American health care company Aetna has convinced a California court to transfer its antitrust action claiming that Gilead and other drugmakers used pay-for-delay tactics to maintain high costs of HIV treatments.   25 April 2022